In this paper by Schuit and colleagues (BMJ 2022;378:e071215, doi:10.1136/bmj-2022-071215, published 14 September 2022), sensitivities of the MPBio and Clinitest rapid antigen tests were transposed in the What this study adds section of the summary points box. The text should have read: The sensitivities of three commercially available rapid antigen tests performed with nasal self-sampling decreased during the emergence of omicron, from 87% to 81% for Flowflex, 80% to 73% for MPBio, and 83% to 70% for Clinitest, with only Clinitest reaching statistical significance.
. 2022 Sep 16;378:o2241. doi: 10.1136/bmj.o2241
Diagnostic accuracy of covid-19 rapid antigen tests with unsupervised self-sampling in people with symptoms in the omicron period: cross sectional study
Collection date 2022.
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
PMCID: PMC9478905 PMID: 36113886
This corrects the article "Diagnostic accuracy of covid-19 rapid antigen tests with unsupervised self-sampling in people with symptoms in the omicron period: cross sectional study", e071215.